This site is optimised for modern browsers. For the best experience, please use Google Chrome, Mozilla Firefox, or Microsoft Edge.

nCoV: Developing CoV-bnMABs for therapy of highly pathogenic coronaviruses including SARS-CoV-2

Published: 25/03/2020
Read Time: minutes
Print this document

The COVID-19 studies on our website have moved.

Please visit the list of nationally prioritised studies.